Makoto Kuroda Selected Research

Filoviridae Infections

11/2020	A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
6/2015	Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.
11/2013	Differential potential for envelope glycoprotein-mediated steric shielding of host cell surface proteins among filoviruses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Kuroda Research Topics

Disease

30	Infections 11/2023 - 05/2002
26	Neoplasms (Cancer) 01/2021 - 01/2002
8	COVID-19 02/2024 - 01/2020
4	Ebola Hemorrhagic Fever 11/2023 - 01/2012
4	Virus Diseases (Viral Diseases) 02/2022 - 01/2017
4	Neoplasm Metastasis (Metastasis) 10/2011 - 01/2002
3	Ulcer 11/2023 - 01/2002
3	Inflammation (Inflammations) 01/2023 - 01/2015
3	Reinfection 01/2023 - 10/2021
3	Pneumonia (Pneumonitis) 01/2023 - 10/2015
3	Filoviridae Infections 11/2020 - 11/2013
3	Stomach Neoplasms (Stomach Cancer) 05/2018 - 01/2017
3	Carcinoma (Carcinomatosis) 09/2017 - 05/2010
3	Hepatocellular Carcinoma (Hepatoma) 02/2011 - 03/2007
3	Adenocarcinoma 05/2010 - 01/2002
2	Diphtheria 06/2023 - 05/2012
2	Viral Pneumonia 01/2023 - 04/2010
2	Abdominal Pain (Pain, Abdominal) 09/2022 - 01/2002
2	Communicable Diseases (Infectious Diseases) 10/2021 - 01/2014
2	T-Cell Leukemia (Leukemia, T Cell) 01/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2021
2	Vesicular Stomatitis 11/2020 - 12/2014
2	Human Influenza (Influenza) 10/2020 - 01/2010
2	Progressive Multifocal Leukoencephalopathy 01/2020 - 01/2017
2	Wounds and Injuries (Trauma) 01/2020 - 07/2017
2	Epstein-Barr Virus Infections 07/2018 - 01/2017
2	Fever (Fevers) 01/2018 - 01/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2013
2	Adenocarcinoma of Lung 09/2017 - 05/2010
2	Ulcerative Colitis 07/2017 - 08/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 02/2017 - 01/2014
2	Abscess 01/2017 - 05/2012
2	Lymphoma (Lymphomas) 01/2017 - 01/2016
2	Anthrax 01/2015 - 08/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2014 - 05/2010
2	Disease Progression 01/2012 - 11/2010
2	Thymoma (Thymic Carcinoma) 04/2011 - 07/2008
2	Hyperbilirubinemia 09/2004 - 04/2002
2	Crigler-Najjar Syndrome 09/2004 - 05/2004
2	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 09/2004 - 02/2004
2	Jaundice (Icterus) 05/2004 - 02/2004
1	Tetanus 11/2023
1	Diabetic Foot 11/2023
1	Enteritis 04/2023
1	Postmortem Changes (Adipocere) 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Appendicitis 09/2022
1	Sepsis (Septicemia) 12/2021

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 02/2024 - 01/2012
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2004
8	Neutralizing AntibodiesIBA 07/2023 - 01/2012
7	AntibodiesIBA 10/2021 - 02/2011
6	Antiviral Agents (Antivirals)IBA 11/2023 - 06/2015
6	Monoclonal AntibodiesIBA 07/2023 - 01/2012
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2010
5	AntigensIBA 01/2021 - 01/2007
5	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2016
4	Messenger RNA (mRNA)IBA 11/2023 - 01/2010
4	N-(2-cyanoethylene)urea (BA 1)IBA 07/2023 - 01/2022
4	Glycoproteins (Glycoprotein)IBA 01/2023 - 11/2013
4	Immunoglobulin G (IgG)IBA 01/2023 - 12/2013
4	Biomarkers (Surrogate Marker)IBA 05/2018 - 01/2015
4	BilirubinIBA 09/2004 - 04/2002
3	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 01/2022
3	human ERBB2 proteinIBA 01/2021 - 10/2020
3	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2002
3	Virulence Factors (Pathogenicity Factors)IBA 01/2018 - 01/2017
2	Diphtheria ToxinIBA 06/2023 - 05/2012
2	Viral RNAIBA 01/2023 - 01/2018
2	NucleotidesIBA 01/2023 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2010
2	COV2-2130IBA 02/2022 - 01/2022
2	nirmatrelvirIBA 02/2022 - 01/2022
2	molnupiravirIBA 02/2022 - 01/2022
2	COV2-2196IBA 02/2022 - 01/2022
2	Nucleic AcidsIBA 12/2021 - 01/2021
2	Estrogen ReceptorsIBA 01/2021 - 01/2021
2	favipiravirIBA 01/2021 - 10/2020
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2021
2	InterferonsIBA 11/2020 - 04/2004
2	Immunoglobulin M (IgM)IBA 09/2019 - 01/2018
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2018 - 02/2011
2	Anti-Infective Agents (Microbicides)IBA 01/2018 - 01/2017
2	Mucin-1 (CA 15-3 Antigen)IBA 05/2016 - 06/2011
2	Capsules (Microcapsules)IBA 10/2015 - 02/2011
2	N-nitroso-N-methyl-4-nitroanilineIBA 04/2011 - 07/2008
1	ToxoidsIBA 11/2023
1	Erythromycin (Erycette)FDA LinkGeneric 04/2023
1	FluoroquinolonesIBA 04/2023
1	Aluminum Hydroxide (Algeldrate)FDA Link 01/2023
1	P-2 (P 2)IBA 01/2023
1	Quil AIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2022
1	mRNA VaccinesIBA 01/2022

Therapy/Procedure

10	Therapeutics 11/2020 - 01/2002
3	Lasers (Laser) 11/2019 - 07/2017
3	Drug Therapy (Chemotherapy) 10/2011 - 01/2002
2	Pancreaticoduodenectomy 01/2020 - 01/2004
1	Surgical Amputation (Amputations) 11/2023
1	Aftercare (After-Treatment) 09/2022